Doxepin is not an SSRI. It is a tricyclic antidepressant (TCA), an older class of medication that works differently and affects a broader range of brain chemicals than SSRIs do. The two drug classes are sometimes confused because both influence serotonin, but they belong to distinct categories with different mechanisms, side effect profiles, and clinical uses.
How Doxepin Actually Works
Doxepin increases the concentration of two neurotransmitters in the brain: serotonin and norepinephrine. It does this by blocking their reabsorption back into nerve cells, which keeps them active in the space between neurons for longer. SSRIs, by contrast, target only serotonin. That word “selective” in Selective Serotonin Reuptake Inhibitor is the key distinction.
But serotonin and norepinephrine reuptake are only part of the story. Doxepin also blocks histamine receptors (both H1 and H2), certain adrenaline-related receptors, and muscarinic receptors. This broad receptor activity is what gives tricyclics their wider range of effects, and their wider range of side effects. At low doses, doxepin binds to histamine receptors roughly 100 times more strongly than it binds to serotonin or norepinephrine receptors, which is why low-dose doxepin functions essentially as an antihistamine rather than an antidepressant.
What Doxepin Is Prescribed For
Doxepin has two very different uses depending on the dose. At higher doses (typically 75 to 150 mg), it treats depression and anxiety, working through its effects on serotonin and norepinephrine. At very low doses (3 to 6 mg), it treats insomnia, specifically difficulty staying asleep, by leveraging its strong histamine-blocking properties. These low-dose and high-dose formulations are marketed under different brand names, even though the active ingredient is the same.
Doxepin’s ability to block histamine receptors also gives it anti-itch properties. It is sometimes used in topical form for skin conditions involving chronic itching.
How TCAs Differ From SSRIs
SSRIs like sertraline, fluoxetine, and escitalopram became the first-line treatment for depression largely because they are more targeted. By acting primarily on serotonin and leaving other receptor systems alone, SSRIs tend to cause fewer side effects than tricyclics. TCAs like doxepin, because they affect so many receptors at once, commonly cause drowsiness, dry mouth, constipation, blurred vision, and weight gain. The histamine-blocking action drives the sedation, while the muscarinic receptor effects account for the dry mouth and urinary issues.
SSRIs carry their own side effect concerns. They can worsen anxiety in the early weeks of treatment and cause gastrointestinal symptoms like nausea and stomach discomfort. In some clinical situations, a tricyclic like doxepin may actually be preferred. For patients dealing with both depression and significant GI complaints, for example, doxepin can address both problems where an SSRI might aggravate the stomach issues.
The safety profile in overdose is another important difference. TCAs are considerably more dangerous if taken in excess compared to SSRIs, which is one reason SSRIs largely replaced them as the go-to antidepressant. Alcohol increases the risk of a serious reaction with doxepin, more so than with most SSRIs.
Side Effects and Safety Concerns
Like all antidepressants, doxepin carries an FDA boxed warning about increased risk of suicidal thoughts and behavior in children, adolescents, and young adults under 25. This risk was not seen in adults over 24, and in adults 65 and older, antidepressants were actually associated with reduced risk compared to placebo. Doxepin is not recommended for children under 12.
Doxepin is specifically contraindicated in people with glaucoma or a tendency toward urinary retention, both of which can be worsened by its receptor-blocking effects. Older adults need particular caution because doxepin’s sedating properties can cause confusion and excessive drowsiness. People with undiagnosed bipolar disorder may experience a manic episode if treated with doxepin (or any antidepressant) without a mood stabilizer.
For nursing mothers, doxepin poses a specific concern: there have been reports of breathing problems and excessive drowsiness in infants whose mothers were taking the drug. Its safety in pregnancy has not been established.
Why the Confusion Exists
People often search whether doxepin is an SSRI because both drug types are prescribed for depression and both involve serotonin. The terminology can be misleading if you only know that doxepin “works on serotonin.” It does, but so do many drug classes, including tricyclics, SNRIs, and MAOIs. The differences lie in how many neurotransmitter systems a drug touches, how selectively it acts, and what additional receptors it affects. Doxepin is one of the least selective antidepressants available, which makes it useful for multiple conditions but also gives it a broader side effect profile than any SSRI.